Kristina Navrazhina

8PUBLICATIONS
9CO-AUTHORS
Cardiology (incl. cardiovascular diseases)AllergyAutoimmunityEpidemiological modellingMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 27, 2022
Ustekinumab reduces serum protein levels associated with cardiovascular risk in psoriasis vulgaris.

Merav Koschitzky, Kristina Navrazhina, Michael S Garshick

|Feb 22, 2022
Interleukin-17RA blockade by brodalumab decreases inflammatory pathways in hidradenitis suppurativa skin and serum.

Kristina Navrazhina, John W Frew, David Grand

|Sep 25, 2020
Weekly administration of brodalumab in hidradenitis suppurativa: an open-label cohort study.

J W Frew, K Navrazhina, M Sullivan-Whalen

|Sep 15, 2020
Dermal tunnels influence time to clinical response and family history influences time to loss of clinical response in patients with hidradenitis suppurativa treated with adalimumab.

J W Frew, C S Jiang, N Singh

|Jul 01, 2020
Doppler ultrasound-based noninvasive biomarkers in hidradenitis suppurativa: evaluation of analytical and clinical validity.

D Grand, J W Frew, K Navrazhina

|Oct 09, 2019
No evidence that impaired Notch signalling differentiates hidradenitis suppurativa from other inflammatory skin diseases.

J W Frew, K Navrazhina

Pageof 2

Frequent Collaborators

7 joint publications

John W Frew

3 joint publications

James G Krueger

2 joint publications

Juana Gonzalez

2 joint publications

Sandra Garcet